Lipid nanoparticles for gene therapy in ocular diseases.

Christian Chapa González, Jessica Victoria Martínez Saráoz, Jorge Alberto Roacho Pérez, Imelda Olivas Armendáriz
{"title":"Lipid nanoparticles for gene therapy in ocular diseases.","authors":"Christian Chapa González, Jessica Victoria Martínez Saráoz, Jorge Alberto Roacho Pérez, Imelda Olivas Armendáriz","doi":"10.1007/s40199-023-00455-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Lipid nanoparticles, as a nucleic acid delivery system, have been used as an alternative to treat ocular diseases, since they can cross the ocular barrier and efficiently transfecting nucleic acids to various cells of the eye. The size influences the transfection of genes, biological distribution, diffusion, and cellular uptake. It is therefore important to establish a relationship between size, formulation, and encapsulation percentage.</p><p><strong>Evidence acquisition: </strong>In this review, we used a search strategy to compare studies of nanomedicine systems aimed at eye diseases where the size of the nanoparticles and the efficiency of encapsulation of genetic material are reported based on the criteria of Preferred Reporting Items for Systematic Reviews (PRISMA ScR 2020 guidelines).</p><p><strong>Results: </strong>Out of the initial 5932, 169 studies met the inclusion criteria and were included to form the basis of the analysis. Nanoparticles reported are composed mainly of PEG-modified lipids, cholesterol, and cationic lipids, that in combination with messenger or interference RNA, allow the formulation of a nanoparticle with an encapsulation efficiency greater than 95%. The diseases treated mainly focus on conditions related to the retina and cornea. Certain characteristics of nanoparticles increase encapsulation efficiency, such as the size of the nanoparticle and the charge of the outer layer of the nanoparticle.</p><p><strong>Conclusion: </strong>It is still unknown what characteristics lipid nanoparticles should have to successfully treat human eye illnesses. The in vitro and in vivo investigations covered in this review, however, present encouraging results. To improve encapsulation effectiveness and disease gene silencing, nanoparticle formulation is essential. The most stable nanoparticles are those made mostly of cationic lipids, PEG lipids, and cholesterol, which also effectively encapsulate RNA. The encapsulation efficiency is not only influenced by size, but also by other factors such as methods of preparation.</p>","PeriodicalId":10961,"journal":{"name":"Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences","volume":"31 1","pages":"75-82"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238339/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40199-023-00455-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/2/15 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Lipid nanoparticles, as a nucleic acid delivery system, have been used as an alternative to treat ocular diseases, since they can cross the ocular barrier and efficiently transfecting nucleic acids to various cells of the eye. The size influences the transfection of genes, biological distribution, diffusion, and cellular uptake. It is therefore important to establish a relationship between size, formulation, and encapsulation percentage.

Evidence acquisition: In this review, we used a search strategy to compare studies of nanomedicine systems aimed at eye diseases where the size of the nanoparticles and the efficiency of encapsulation of genetic material are reported based on the criteria of Preferred Reporting Items for Systematic Reviews (PRISMA ScR 2020 guidelines).

Results: Out of the initial 5932, 169 studies met the inclusion criteria and were included to form the basis of the analysis. Nanoparticles reported are composed mainly of PEG-modified lipids, cholesterol, and cationic lipids, that in combination with messenger or interference RNA, allow the formulation of a nanoparticle with an encapsulation efficiency greater than 95%. The diseases treated mainly focus on conditions related to the retina and cornea. Certain characteristics of nanoparticles increase encapsulation efficiency, such as the size of the nanoparticle and the charge of the outer layer of the nanoparticle.

Conclusion: It is still unknown what characteristics lipid nanoparticles should have to successfully treat human eye illnesses. The in vitro and in vivo investigations covered in this review, however, present encouraging results. To improve encapsulation effectiveness and disease gene silencing, nanoparticle formulation is essential. The most stable nanoparticles are those made mostly of cationic lipids, PEG lipids, and cholesterol, which also effectively encapsulate RNA. The encapsulation efficiency is not only influenced by size, but also by other factors such as methods of preparation.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于眼部疾病基因治疗的脂质纳米颗粒。
目的:脂质纳米粒子作为一种核酸递送系统,可以穿过眼屏障,有效地将核酸转染到眼部的各种细胞中,因此已被用作治疗眼部疾病的替代方法。尺寸会影响基因的转染、生物分布、扩散和细胞吸收。因此,建立尺寸、配方和封装百分比之间的关系非常重要:在本综述中,我们采用了一种搜索策略,根据《系统性综述首选报告项目》(PRISMA ScR 2020 指南)的标准,比较了针对眼部疾病的纳米药物系统的研究,其中报告了纳米颗粒的大小和封装遗传物质的效率:在最初的 5932 项研究中,有 169 项符合纳入标准,并被纳入分析基础。所报道的纳米颗粒主要由 PEG 改性脂质、胆固醇和阳离子脂质组成,这些物质与信使或干扰 RNA 结合可配制出封装效率超过 95% 的纳米颗粒。治疗的疾病主要集中在视网膜和角膜方面。纳米粒子的某些特性可提高封装效率,如纳米粒子的大小和纳米粒子外层的电荷:要成功治疗人类眼疾,脂质纳米粒子应具备哪些特性仍是未知数。不过,本综述所涉及的体外和体内研究结果令人鼓舞。要提高封装效果和疾病基因沉默,纳米颗粒的配方至关重要。最稳定的纳米粒子主要由阳离子脂质、PEG 脂质和胆固醇制成,它们也能有效封装 RNA。封装效率不仅受尺寸影响,还受制备方法等其他因素的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Correction: Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies. A rare case of phenobarbital-induced leukocytoclastic vasculitis. Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach. Simulation of drug-drug interactions between breast cancer chemotherapeutic agents and antiemetic drugs. The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1